R. Tamura et al.
FULL PAPER
= 3.1 Hz (13C-14N coupling)], 65.8 [t, J = 3.1 Hz (13C-14N coup-
ling)], 67.9, 70.3, 70.9, 72.7, 115.8, 123.0, 127.0, 129.8, 132.8, 141.7,
143.7, 157.4, 168.6 ppm. C26H38N2O7S (522.65): calcd. C 59.75, H
7.33, N 5.36; found C 59.57, H 7.37, N 5.18.
48.3, 60.9, 62.6, 67.9, 70.3, 70.9, 72.8, 97.1, 115.9, 123.0, 128.8,
132.7, 138.6, 146.4, 157.4, 168.6 ppm. C26H37IN2O7S (648.55):
calcd. C 48.15, H 5.75, N 4.32; found C 48.23, H 5.60, N 4.33.
(؎)-N-{2-[4-(2-Hydroxy-3-ethoxypropoxy)phenylcarbamoyl]ethyl}-
N-methylpiperidinium p-Toluenesulfonate [(؎)-2d]: M.p. 120.6 °C
(؎)-N-{2-[4-(2-Hydroxy-3-ethoxypropoxy)phenylcarbamoyl]ethyl}-
piperidine (5): To a mixture of 3 (6.00 g, 17 mmol) and water
(60 mL) was added piperidine (5 mL) dropwise over 10 min at 0 °C
with stirring. The reaction mixture was warmed to room tempera-
ture and stirred vigorously for 48 h. The resulting mixture was ex-
tracted with CH2Cl2 (3ϫ30 mL), and the combined organic phase
was dried with anhydrous MgSO4, filtered, and evaporated, fol-
lowed by recrystallization from EtOH to give pure 5 as a colorless
(DSC). IR (KBr): ν = 3364, 3067, 2870, 1689, 1612, 1508, 1222,
˜
1120, 841 cm–1. 1H NMR (500 MHz, CD3OD): δ = 1.19 (t, J =
7.0 Hz, 3 H), 1.67 (m, 2 H), 1.90 (quint, J = 5.7 Hz, 4 H), 2.35 (s,
3 H), 2.91 (t, J = 7.3 Hz, 2 H), 3.07 (s, 3 H), 3.38 (t, J = 5.8 Hz, 4
H), 3.52–3.59 (m, 4 H), 3.72 (t, J = 7.3 Hz, 2 H), 3.94 (dd, J = 5.6,
9.4 Hz, 1 H), 4.00–4.06 (m, 2 H), 6.90 (d, J = 9.1 Hz, 2 H), 7.21
(d, J = 8.0 Hz, 2 H), 7.44 (d, J = 9.1 Hz, 2 H), 7.70 (d, J = 8.0 Hz,
2 H) ppm. 13C NMR (126 MHz, CD3OD): δ = 15.4, 21.0, 21.3,
22.0, 30.1, 48.3, 61.0, 62.6, 67.9, 70.3, 70.9, 72.7, 115.9, 123.0,
127.0, 129.8, 132.8, 141.7, 143.7, 157.4, 168.6 ppm. C27H40N2O7S
(536.68): calcd. C 60.42, H 7.51, N 5.22; found C 60.34, H 7.62, N
5.23.
solid (4.86 g, 14 mmol, 82% yield). M.p. 94.2 °C (DSC). IR (KBr):
1
ν = 3478, 2947, 2783, 1681, 1606, 1517, 1246, 1122, 1058 cm–1. H
˜
NMR (500 MHz, CDCl3): δ = 1.22 (t, J = 7.0 Hz, 3 H), 1.54 (br.,
2 H), 1.68 (quint, J = 5.5 Hz, 4 H), 2.49 (dd, J = 5.0, 6.9 Hz, 2 H),
2.53 (br., 4 H), 2.65 (dd, J = 5.0, 6.9 Hz, 2 H), 3.53–3.59 (m, 3 H),
3.62 (dd, J = 4.5, 9.8 Hz, 1 H), 3.97–4.03 (m, 2 H), 4.15 (quint, J
= 5.4 Hz, 1 H), 6.88 (ddd, J = 1.8, 3.8, 10.2 Hz, 2 H), 7.46 (ddd, J
= 1.8, 3.8, 10.2 Hz, 2 H), 11.20 (s, 1 H) ppm. 13C NMR (126 MHz,
CDCl3): δ = 15.1, 24.3, 26.3, 32.5, 53.6, 54.4, 67.0, 69.2, 69.5, 71.3,
115.0, 120.9, 132.7, 154.8, 170.6 ppm. C19H30N2O4·0.3H2O
(355.86): C 64.13, H 8.67, N 7.87; found C 64.10, H 8.56, N 7.66.
General Procedure for the Preferential Enrichment Experiment of
(؎)-1a, (؎)-1b, and (؎)-1c (Figure 4): (؎)-1a (1.15 , 500.0 mg,
0.921 mmol) was dissolved in EtOH (0.8 mL) on heating. The re-
sulting threefold supersaturated solution was allowed to stand at
–20 °C, and the ee value of the mother liquor was measured occa-
sionally. The solution was left until the ee value reached equilib-
rium after the crystals were deposited. Consequently, it took 7 d
for the first recrystallization. The deposited crystals were separated
from the mother liquor by filtration. After evaporation of the sol-
vent, S-enriched 1a (50.2 mg, 75.0% ee) was obtained as a viscous
colorless oil. The slightly R-enriched deposited crystals (449.6 mg,
8.4% ee) were subsequently recrystallized from EtOH (0.7 mL) in
a similar manner, which led to the deposition of antipodal S-rich
crystals (390.3 mg, 2.4% ee) and the enrichment of the R enanti-
omer in the mother liquor, from which R-enriched 1a (59.2 mg,
79.5% ee) was obtained as a viscous oil. Similar crystallizations
were repeated four times in all.
(Ϯ)-2a, (Ϯ)-2b, (Ϯ)-2c, and (Ϯ)-2d were prepared in an analogous
way to the synthesis of (Ϯ)-1a.
(؎)-N-{2-[4-(2-Hydroxy-3-ethoxypropoxy)phenylcarbamoyl]ethyl}-
N-methylpiperidinium p-Chlorobenzenesulfonate [(؎)-2a]: M.p.
114.4 °C (DSC). IR (KBr): ν = 3428, 3081, 2870, 1672, 1613, 1513,
˜
1
1225, 1119, 841 cm–1. H NMR (500 MHz, CD3OD): δ = 1.19 (t,
J = 7.0 Hz, 3 H), 1.68 (m, 2 H), 1.91 (quint, J = 5.7 Hz, 4 H), 2.91
(t, J = 7.3 Hz, 2 H), 3.08 (s, 3 H), 3.40 (t, J = 5.8 Hz, 4 H), 3.52–
3.59 (m, 4 H), 3.74 (t, J = 7.3 Hz, 2 H), 3.93 (dd, J = 5.6, 9.4 Hz,
1 H), 4.00–4.06 (m, 2 H), 6.90 (d, J = 9.1 Hz, 2 H), 7.41 (d, J =
8.7 Hz, 2 H), 7.43 (d, J = 9.1 Hz, 2 H), 7.78 (d, J = 8.7 Hz, 2 H)
ppm. 13C NMR (126 MHz, CD3OD): δ = 15.4, 21.0, 22.0, 30.1,
48.3, 61.0, 62.6, 67.9, 70.3, 71.0, 72.8, 115.9, 123.0, 128.7, 129.4,
132.7, 137.1, 145.4, 157.4, 168.6 ppm. C26H37ClN2O7S (557.10):
calcd. C 56.05, H 6.69, N 5.03; found C 56.16, H 6.53, N 5.04.
An analogous procedure was use for (Ϯ)-1b (Figure 5) and (Ϯ)-1c
(Figure 6).
For reference, (S)-enriched 1a–c were synthesized from commer-
cially available (S)-epichlorohydrin. (S)-1a (90.9% ee): [α]2D0
=
(؎)-N-{2-[4-(2-Hydroxy-3-ethoxypropoxy)phenylcarbamoyl]ethyl}-
N-methylpiperidinium p-Bromobenzenesulfonate [(؎)-2b]: M.p.
+1.84(1) (c = 2.138, MeOH); (S)-1b (90.9% ee): [α]2D0 = +1.41(2) (c
= 2.137, MeOH); (S)-1c (93.6% ee): [α]2D0 = +1.97(2) (c = 2.136,
116.5 °C (DSC). IR (KBr): ν = 3428, 3078, 2868, 1672, 1609, 1507, MeOH).
˜
1222, 1116, 839 cm–1. H NMR (500 MHz, CD3OD): δ = 1.19 (t,
1
X-ray Crystallographic Analysis of the δ-Form of 1c, the β-Form of
J = 7.0 Hz, 3 H), 1.68 (m, 2 H), 1.92 (quint, J = 5.7 Hz, 4 H), 2.91
(t, J = 7.3 Hz, 2 H), 3.08 (s, 3 H), 3.40 (t, J = 5.8 Hz, 4 H), 3.52–
3.59 (m, 4 H), 3.74 (t, J = 7.3 Hz, 2 H), 3.93 (dd, J = 5.6, 9.4 Hz,
1 H), 4.00–4.05 (m, 2 H), 6.90 (d, J = 9.1 Hz, 2 H), 7.44 (d, J =
9.1 Hz, 2 H), 7.57 (d, J = 8.7 Hz, 2 H), 7.72 (d, J = 8.7 Hz, 2 H)
ppm. 13C NMR (126 MHz, CD3OD): δ = 15.4, 21.0, 22.0, 30.1,
48.3, 60.9, 62.6, 67.9, 70.2, 70.9, 72.7, 115.9, 123.0, 125.3, 128.9,
132.5, 132.7, 145.8, 157.4, 168.6 ppm. C26H37BrN2O7S (601.55):
calcd. C 51.91, H 6.20, N 4.66; found C 51.61, H 6.01, N 4.46.
1d, and the α2-Form of 2a: For the X-ray crystallographic analysis,
the single crystal was mounted in a sealed capillary. The data col-
lections were performed at 296 K with an Enraf–Nonius Kappa
CCD diffractometer with graphite monochromated Mo-Kα radia-
tion for the δ-form of (Ϯ)-1c, at 296 K with a Rigaku CCD dif-
fractometer with graphite monochromated Mo-Kα radiation for the
β-form of (Ϯ)-1d, and at 173 K with a Rigaku RAXIS RAPID
diffractometer with graphite monochromated Mo-Kα radiation for
the α2-form of (Ϯ)-2a. All of the crystallographic calculations were
performed by using the CrystalStructure software package of Ri-
gaku and Rigaku/MSC. The crystal structures were solved by direct
(؎)-N-{2-[4-(2-Hydroxy-3-ethoxypropoxy)phenylcarbamoyl]ethyl}-
N-methylpiperidinium p-Iodobenzenesulfonate [(؎)-2c]: M.p.
118.6 °C (DSC). IR (KBr): ν = 3421, 3080, 2866, 1671, 1610, 1507, methods and refined by using full-matrix least-squares. All non-
˜
1211, 1112, 833 cm–1. H NMR (500 MHz, CD3OD): δ = 1.19 (t,
J = 7.0 Hz, 3 H), 1.68 (m, 2 H), 1.91 (quint, J = 5.7 Hz, 4 H), 2.91
(t, J = 7.3 Hz, 2 H), 3.08 (s, 3 H), 3.39 (t, J = 5.8 Hz, 4 H), 3.52–
3.59 (m, 4 H), 3.74 (t, J = 7.3 Hz, 2 H), 3.94 (dd, J = 5.6, 9.4 Hz,
hydrogen atoms were refined anisotropically. The summary of the
fundamental crystal data and experimental parameters for the
structure determination is given in Table 2. CCDC-679608 [for (Ϯ)-
1c], -679609 [for (Ϯ)-1d], and -679610 [ for(Ϯ)-2a] contain the sup-
1
1 H), 4.00–4.06 (m, 2 H), 6.90 (d, J = 9.1 Hz, 2 H), 7.44 (d, J = plementary crystallographic data for this paper. These data can be
9.1 Hz, 2 H), 7.56 (d, J = 8.7 Hz, 2 H), 7.77 (d, J = 8.7 Hz, 2 H)
obtained free of charge from The Cambridge Crystallographic
Data Centre via www.ccdc.cam.ac.uk/data_request/cif.
ppm. 13C NMR (126 MHz, CD3OD): δ = 15.4, 21.0, 22.0, 30.1,
3504
www.eurjoc.org
© 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2008, 3496–3505